Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score

Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score

Objective: To test the hypothesis that the Monoclonal Antibody Screening Score performs consistently better in identifying the need for monoclonal antibody infusion throughout each “wave” of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant predominance during the coronavirus dise...

Full description

Bibliographic Details
Main Authors: Patrick W. Johnson, BS, Katie L. Kunze, PhD, Jonathon W. Senefeld, PhD, Jorge E. Sinclair, MD, Shahin Isha, MBBS, Parthkumar H. Satashia, MBBS, Shivang Bhakta, MD, Jennifer B. Cowart, MD, Wendelyn Bosch, MD, Jack O’Horo, MD, Sadia Z. Shah, MD, Hani M. Wadei, MD, Michael A. Edwards, MD, Benjamin D. Pollock, PhD, Alana J. Edwards, Sidna Scheitel-Tulledge, MD, Caroline G. Clune, MD, Sara N. Hanson, DO, Richard Arndt, PharmD, Alexander Heyliger, PharmD, Cory Kudrna, MBA, Dennis M. Bierle, MD, Jason R. Buckmeier, BS, Maria Teresa A. Seville, MD, Robert Orenstein, DO, Claudia Libertin, MD, Ravindra Ganesh, MD, Pablo Moreno Franco, MD, Raymund R. Razonable, MD, Rickey E. Carter, PhD, Devang K. Sanghavi, MD, Leigh L. Speicher, MD
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454823000036

Internet

http://www.sciencedirect.com/science/article/pii/S2542454823000036

Similar Items